AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32896291 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 76
Study 36007135 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mL sodium bicarbonate in 240 mL isotonic nasal irrigation twice daily for 14 days
Number of subjects: 79
Study 36007135 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mL povidone-iodine 10% in 240 mL isotonic nasal irrigation twice daily for 14 days
Number of subjects: 79
Study 36007135 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation (both groups)
Number of subjects: 79
Study 36007135 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily irrigation (regardless of additive)
Number of subjects: 79
Study 36007135 — intervention group
Group type: COMPARATOR
Intervention: Nasal irrigation participants
Number of subjects: 79
Study 34704970 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indomethacin administered every 8 hours for 6 doses
Number of subjects: 42
Study 34704970 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered every 8 hours for 6 doses
Number of subjects: 42
Study 34704970 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 42
Study 34704970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32458980 — intervention group
Group type: EXPERIMENTAL
Intervention: DIM 100 mg × 1/day for 1 year
Number of subjects: 23
Study 32458980 — intervention group
Group type: COMPARATOR
Intervention: DIM-untreated age- and menopausal-status-matched women
Number of subjects: 23
Study 35026158 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (60,000 IU per month)
Number of subjects: 21315
Study 35026158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21315
Study 33840570 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric tools
Number of subjects: 34
Study 33840570 — intervention group
Group type: COMPARATOR
Intervention: Traditional oscillating saw
Number of subjects: 34
Study 33287868 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Jin’s three-needle acupuncture) as adjunctive therapy with methadone maintenance therapy (MMT) for 30 min per session, 18 sessions over 6 weeks (3 per week).
Number of subjects: 140
Study 33287868 — intervention group
Group type: COMPARATOR
Intervention: Routine care (MMT only).
Number of subjects: 140
Study 36155742 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text messages to parents (twice daily for 1 year)
Number of subjects: 268
Study 36155742 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text messages to parents
Number of subjects: 268
Study 33790343 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper extremity treatment with sonification techniques
Number of subjects: 65
Study 33790343 — intervention group
Group type: COMPARATOR
Intervention: Standard upper extremity motor rehabilitation (Control)
Number of subjects: 65
Study 32788051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalfampridine (4-AP, 10 mg BID)
Number of subjects: 11
Study 32788051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 35462324 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Thinking Strategies (VTS) integrated into three skills lab sessions via on-site sessions or real-time online videoconferencing sessions
Number of subjects: 60
Study 35462324 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Thinking Strategies (VTS)
Number of subjects: 60
Study 33407796 — intervention group
Group type: EXPERIMENTAL
Intervention: APOSEC (cell-free secretome of peripheral blood mononuclear cells) applied topically three times weekly for 4 weeks.
Number of subjects: 132
Study 33407796 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied topically three times weekly for 4 weeks.
Number of subjects: 132
Study 35397090 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidified high‐flow nasal cannula (HHHFNC)
Number of subjects: 124
Study 35397090 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 124
Study 33861881 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-and-text HWL (n = 135)
Number of subjects: 399
Study 33861881 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only HWL (n = 129)
Number of subjects: 399
Study 33861881 — intervention group
Group type: COMPARATOR
Intervention: No HWL (n = 135)
Number of subjects: 399
Study 33861881 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-and-text HWL
Number of subjects: 399
Study 33861881 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only HWL
Number of subjects: 399
Study 34187130 — intervention group
Group type: EXPERIMENTAL
Intervention: Tualang honey nasal dressing (2 mL)
Number of subjects: 32
Study 34187130 — intervention group
Group type: COMPARATOR
Intervention: Steroid nasal dressing (triamcinolone 20 mg/mL, 2 mL)
Number of subjects: 32
Study 32200659 — intervention group
Group type: EXPERIMENTAL
Intervention: QL0902 (50 mg subcutaneous injection)
Number of subjects: 68
Study 32200659 — intervention group
Group type: COMPARATOR
Intervention: Reference Etanercept (50 mg subcutaneous injection)
Number of subjects: 68
Study 32200659 — intervention group
Group type: COMPARATOR
Intervention: Comparison of QL0902 and Reference Etanercept
Number of subjects: 68
Study 32200659 — intervention group
Group type: EXPERIMENTAL
Intervention: QL0902
Number of subjects: 68
Study 32589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-tests offered to sexual partners
Number of subjects: 921
Study 32589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-tests offered during transactional sex encounters
Number of subjects: 921
Study 32589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive HIV test results
Number of subjects: 921
Study 32589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Not offered a self-test
Number of subjects: 921
Study 32589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Refused to self-test
Number of subjects: 921
Study 35081275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0
Study 35081275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34280297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored yoga program (intervention group)
Number of subjects: 0
Study 34280297 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 32088398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair Yoga (CY)
Number of subjects: 112
Study 32088398 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 112
Study 35129525 — intervention group
Group type: COMPARATOR
Intervention: C‐Alc
Number of subjects: 3213
Study 35129525 — intervention group
Group type: EXPERIMENTAL
Intervention: PI‐Alc
Number of subjects: 3213
Study 33412596 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (low-molecular-weight heparin or unfractionated heparin)
Number of subjects: 2574
Study 33412596 — intervention group
Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 2574
Study 33412596 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 2574
Study 32554025 — intervention group
Group type: EXPERIMENTAL
Intervention: swCRTdesign R package
Number of subjects: 0
Study 32554025 — intervention group
Group type: EXPERIMENTAL
Intervention: GUI for swCRTdesign
Number of subjects: 0
Study 43637190 — intervention group
Group type: COMPARATOR
Intervention: 2 g oral dose of amoxicillin (Amoxil®)
Number of subjects: 20
Study 43637190 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g oral dose of amoxicillin with 100 mg of sodium diclofenac (Voltaren®)
Number of subjects: 20
Study 35319989 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 35319989 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined high-dose radiotherapy and adoptive NK cell transfer
Number of subjects: 0
Study 33270354 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI increase before age 6 years
Number of subjects: 6130
Study 33270354 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI increase between ages 11 and 12
Number of subjects: 6130
Study 33270354 — intervention group
Group type: EXPERIMENTAL
Intervention: Life course BMI associations with asthma and pulmonary function impairment at age 12 and asthma at age 17
Number of subjects: 6130
Study 35466576 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Inclusion context (SI)
Number of subjects: 92
Study 35466576 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Exclusion context (SE)
Number of subjects: 92
Study 32092518 — intervention group
Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 25°C for 42 days
Number of subjects: 5
Study 32092518 — intervention group
Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 28°C for 42 days
Number of subjects: 5
Study 32092518 — intervention group
Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 31°C for 42 days
Number of subjects: 5
Study 32092518 — intervention group
Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 34°C for 42 days
Number of subjects: 5
Study 32092518 — intervention group
Group type: COMPARATOR
Intervention: Control group at 25°C for 42 days
Number of subjects: 5
Study 33671082 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal-intensity aerobic exercise
Number of subjects: 22
Study 33671082 — intervention group
Group type: COMPARATOR
Intervention: Control group (48 h protocol)
Number of subjects: 22
Study 33671082 — intervention group
Group type: EXPERIMENTAL
Intervention: ME/CFS (48 h protocol)
Number of subjects: 22
Study 33671082 — intervention group
Group type: EXPERIMENTAL
Intervention: ME/CFS (72 h protocol)
Number of subjects: 22
Study 35183991 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy (TRT) of 60 Gy/40 fractions
Number of subjects: 150
Study 35183991 — intervention group
Group type: COMPARATOR
Intervention: Thoracic radiotherapy (TRT) of 45 Gy/30 fractions
Number of subjects: 150
Study 35183991 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms (60 Gy and 45 Gy)
Number of subjects: 150
Study 33677353 — intervention group
Group type: EXPERIMENTAL
Intervention: SKIN intervention (two-session intervention with psychoeducation, behavioral skills demonstrations, and motivational interviewing)
Number of subjects: 252
Study 33677353 — intervention group
Group type: EXPERIMENTAL
Intervention: SKIN intervention
Number of subjects: 252
Study 33677353 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only (AO) condition
Number of subjects: 252
Study 36054754 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced Instruction (SI)
Number of subjects: 148
Study 36054754 — intervention group
Group type: COMPARATOR
Intervention: Mass Instruction (MI)
Number of subjects: 148
Study 36054754 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised practice sessions
Number of subjects: 148
Study 34996514 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading a book in bed before going to sleep
Number of subjects: 991
Study 33349049 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 screws (4S)
Number of subjects: 2
Study 33349049 — intervention group
Group type: COMPARATOR
Intervention: 6 screws (6S)
Number of subjects: 2
Study 33001711 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA)
Number of subjects: 39
Study 33001711 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA)
Number of subjects: 39
Study 33001711 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 39
Study 33001711 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (Anodal, Cathodal, Sham)
Number of subjects: 39
Study 34162016 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert (DVI) alone
Number of subjects: 208
Study 34162016 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone vaginal insert (DVI) with adjunctive sweeping of membranes (ASM)
Number of subjects: 208
Study 32980658 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with shocking content (Australian school)
Number of subjects: 0
Study 32980658 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with punitive content (American school)
Number of subjects: 0
Study 32980658 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with technical content (European school)
Number of subjects: 0
Study 34715833 — intervention group
Group type: EXPERIMENTAL
Intervention: mLab App intervention including HIV home test kits and standard of preventive care
Number of subjects: 0
Study 34715833 — intervention group
Group type: COMPARATOR
Intervention: Standard of preventive care only
Number of subjects: 0
Study 34715833 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV home test kits and standard of preventive care only
Number of subjects: 0
Study 32531482 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma-tailored pulmonary rehabilitation (AT-PR)
Number of subjects: 61
Study 32531482 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 61
Study 34047872 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + AgNP
Number of subjects: 5
Study 34047872 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% CHX gel + AgNP
Number of subjects: 5
Study 34047872 — intervention group
Group type: COMPARATOR
Intervention: Ca(OH)2
Number of subjects: 5
Study 34047872 — intervention group
Group type: COMPARATOR
Intervention: 2% CHX gel
Number of subjects: 5
Study 34047872 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 5
Study 32589073 — intervention group
Group type: EXPERIMENTAL
Intervention: CELBESTA®
Number of subjects: 119
Study 32589073 — intervention group
Group type: COMPARATOR
Intervention: CELEBREX®
Number of subjects: 119
Study 34275430 — intervention group
Group type: EXPERIMENTAL
Intervention: Art intervention (n=11)
Number of subjects: 22
Study 34275430 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 22
Study 33563619 — intervention group
Group type: EXPERIMENTAL
Intervention: Deimplementation strategy consisting of education, audit and feedback
Number of subjects: 5
Study 33563619 — intervention group
Group type: COMPARATOR
Intervention: Control group (before intervention)
Number of subjects: 5
Study 33563619 — intervention group
Group type: EXPERIMENTAL
Intervention: Deimplementation strategy
Number of subjects: 5
Study 36428014 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDIC treatment (patient education, supervised exercise, weight loss, insoles, pain medication)
Number of subjects: 100
Study 36428014 — intervention group
Group type: COMPARATOR
Intervention: Written advice (two leaflets)
Number of subjects: 100
Study 36428014 — intervention group
Group type: EXPERIMENTAL
Intervention: KR (Knee Replacement)
Number of subjects: 100
Study 33938874 — intervention group
Group type: EXPERIMENTAL
Intervention: XiaojiDaozhi Decoction
Number of subjects: 200
Study 33938874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 32819305 — intervention group
Group type: EXPERIMENTAL
Intervention: BCD-022
Number of subjects: 225
Study 32819305 — intervention group
Group type: COMPARATOR
Intervention: Reference trastuzumab
Number of subjects: 225
Study 32819305 — intervention group
Group type: EXPERIMENTAL
Intervention: BCD-022 and Reference trastuzumab
Number of subjects: 225
Study 34091726 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 16
Study 34091726 — intervention group
Group type: EXPERIMENTAL
Intervention: FFP2 mask (FFP2)
Number of subjects: 16
Study 34091726 — intervention group
Group type: COMPARATOR
Intervention: No mask (NM)
Number of subjects: 16
Study 34529340 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple bristles three‐sided sonic powered toothbrush
Number of subjects: 52
Study 34529340 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush with flat trimmed bristles
Number of subjects: 52
Study 34519161 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐WAA treatment
Number of subjects: 50
Study 34519161 — intervention group
Group type: COMPARATOR
Intervention: Sham control group
Number of subjects: 50
Study 33794865 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg) once a day for 3 months
Number of subjects: 90
Study 33794865 — intervention group
Group type: COMPARATOR
Intervention: Placebo once a day for 3 months
Number of subjects: 90
Study 33794865 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg) and Placebo
Number of subjects: 90
Study 35144591 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 449
Study 34836391 — intervention group
Group type: EXPERIMENTAL
Intervention: SWAP IT m-health intervention
Number of subjects: 12
Study 34836391 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 12
Study 34632493 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge BD Vacutainer UltraTouch Push Button Blood Collection Set
Number of subjects: 101
Study 34632493 — intervention group
Group type: COMPARATOR
Intervention: 23-gauge BD Vacutainer Standard Push Button Blood Collection Set
Number of subjects: 101
Study 33757321 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led VTE risk assessment program using the Khorana Risk Score
Number of subjects: 0
Study 33757321 — intervention group
Group type: EXPERIMENTAL
Intervention: Khorana Risk Score
Number of subjects: 0
Study 33238936 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional confectionery ad
Number of subjects: 1613
Study 33238936 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudo-healthy confectionery ad
Number of subjects: 1613
Study 33238936 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional confectionery ad + counter-ad
Number of subjects: 1613
Study 33238936 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudo-healthy confectionery ad + counter-ad
Number of subjects: 1613
Study 33238936 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-ad
Number of subjects: 1613
Study 33238936 — intervention group
Group type: COMPARATOR
Intervention: Non-food ad (control)
Number of subjects: 1613
Study 34297221 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (ACTIVE intervention using a fatigue propensity tool)
Number of subjects: 75
Study 34297221 — intervention group
Group type: COMPARATOR
Intervention: Information alone (control group)
Number of subjects: 75
Study 34297221 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (ACTIVE intervention)
Number of subjects: 75
Study 34243077 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial radioembolisation (TARE)
Number of subjects: 285
Study 34243077 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 285
Study 36280851 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril-folic acid
Number of subjects: 20702
Study 33609021 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis extract gel (2% propolis, 0.2% ascorbic acid, 0.2% tocopherol acetate) applied 3 times/day for a week
Number of subjects: 15
Study 33609021 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel applied 3 times/day for a week
Number of subjects: 15
Study 33028387 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers Moving towards Empowerment (MME) intervention
Number of subjects: 0
Study 33028387 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study 33028387 — intervention group
Group type: EXPERIMENTAL
Intervention: MME intervention
Number of subjects: 0
Study 34992091 — intervention group
Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa parallel to chemotherapy (Group A)
Number of subjects: 99
Study 34992091 — intervention group
Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa sequential to chemotherapy (Group B)
Number of subjects: 99
Study 34992091 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Group C)
Number of subjects: 99
Study 33074442 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendritic cell therapy with HSP70 mRNA transfection
Number of subjects: 45
Study 33074442 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 32496624 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular neck implants
Number of subjects: 34
Study 32496624 — intervention group
Group type: COMPARATOR
Intervention: Circular neck implants
Number of subjects: 34
Study 32496624 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 34134822 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure Guide (EG) training and feedback
Number of subjects: 8
Study 34134822 — intervention group
Group type: COMPARATOR
Intervention: Baseline phase (gold-standard exposure therapy training with weekly consultation)
Number of subjects: 8
Study 34134822 — intervention group
Group type: EXPERIMENTAL
Intervention: EG training
Number of subjects: 8
Study 34531274 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 2253651 (nasally applied genioglossus muscle activator via pharyngeal mucosal receptor stimulation)
Number of subjects: 0
Study 32678677 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumagalactomannosides (CGM) (400 mg) with glucosamine hydrochloride (GLN) (500 mg)
Number of subjects: 80
Study 32678677 — intervention group
Group type: COMPARATOR
Intervention: Chondroitin sulfate (CHN) (415 mg) with glucosamine hydrochloride (GLN) (500 mg)
Number of subjects: 80
Study 35394599 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 1298
Study 35394599 — intervention group
Group type: COMPARATOR
Intervention: Mentoring relationship quality
Number of subjects: 1298
Study 32741497 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall size of the social network
Number of subjects: 241
Study 32741497 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of drug users in the pretreatment social network
Number of subjects: 241
Study 32741497 — intervention group
Group type: EXPERIMENTAL
Intervention: Other pretreatment social support network characteristics (i.e., social support)
Number of subjects: 241
Study 36043353 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity rowing (LiR)
Number of subjects: 15
Study 36043353 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity rowing (HiR)
Number of subjects: 15
Study 36043353 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-pause rowing (MpR)
Number of subjects: 15
Study 33647246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure target (100-129 mm Hg)
Number of subjects: 324